According to Zacks, Henry Schein Inc. (HSIC), a global healthcare products and services distributor, is a stock to watch for value investors, currently holding a Zacks Rank #3 (Hold) with a VGM Score of A and a Value Style Score of A. HSIC's attractive valuation metrics include a forward P/E ratio of 14.63, and the consensus earnings estimate for fiscal year 2025 has increased by $0.02 to $4.86 per share following upward revisions by four analysts in the last 60 days.
Henry Schein Inc. (HSIC), a global distributor of healthcare products and services, is highlighted as a noteworthy stock for value-oriented investors despite its current Zacks Rank #3 (Hold). The company's strong appeal, according to the provided analysis, is derived from its 'A' grades in both the Value Style Score and the overall VGM Score. These high style scores, per the Zacks methodology, suggest significant upside potential even for stocks with a 'Hold' rating. This assessment is further supported by HSIC's attractive forward P/E ratio of 14.63. Reinforcing this positive view, four analysts have revised their earnings estimates upwards for fiscal 2025 within the last 60 days, leading to a $0.02 increase in the Zacks Consensus Estimate to $4.86 per share. Additionally, Henry Schein has demonstrated a consistent ability to surpass earnings expectations, evidenced by an average earnings surprise of 2.4%. The article posits that this combination of a #3 Rank with strong style scores and positive estimate revisions makes HSIC a stock that should be on investors' shortlists.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.70
Ticker Sentiment